Your search returned 5 results.

Results
	1.	Pharmacokinetic and dose-finding studies on efpeglenatide in patients with type 2 diabetes. [electronic resource] by Yoon, Kun-Ho Kang, Jahoon Kwon, Se Chang Trautmann, Michael E Hompesch, Marcus Stewart, John Sorli, Christopher H Producer: 20210624 In: Diabetes, obesity & metabolism vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Efficacy and safety of once-monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo-controlled, 16-week randomized dose-finding study. [electronic resource] by Del Prato, Stefano Kang, Jahoon Trautmann, Michael E Stewart, John Sorli, Christopher H Derwahl, Michael Soto, Alfonso Yoon, Kun-Ho Producer: 20210624 In: Diabetes, obesity & metabolism vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study. [electronic resource] by Pratley, Richard E Kang, Jahoon Trautmann, Michael E Hompesch, Marcus Han, OakPil Stewart, John Sorli, Christopher H Jacob, Stephan Yoon, Kun-Ho Producer: 20200928 In: Diabetes, obesity & metabolism vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Once-Weekly Efpeglenatide Dose-Range Effects on Glycemic Control and Body Weight in Patients With Type 2 Diabetes on Metformin or Drug Naive, Referenced to Liraglutide. [electronic resource] by Rosenstock, Julio Sorli, Christopher H Trautmann, Michael E Morales, Cristóbal Wendisch, Ulrich Dailey, George Hompesch, Marcus Choi, In Young Kang, Jahoon Stewart, John Yoon, Kun-Ho Producer: 20200518 In: Diabetes care vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial. [electronic resource] by Park, Yeon Hee Lee, Kyung-Hun Sohn, Joo Hyuk Lee, Keun Seok Jung, Kyung Hae Kim, Jee-Hyun Lee, Ki Hyeong Ahn, Jin Seok Kim, Tae-Yong Kim, Gun Min Park, In Hae Kim, Sung-Bae Kim, Se Hyun Han, Hye Sook Im, Young-Hyuck Ahn, Jin-Hee Kim, Jung-Yong Kang, Jahoon Im, Seock-Ah Producer: 20190314 In: International journal of cancer vol. 143 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)